MSTN and type 1 diabetes mellitus: Overall, data here and elsewhere (Arrieta et al., 2019) suggest that, in our otherwise healthy cohort of persons with T1D, myostatin may be operating as a homeostatic, rather than pathological, regulator of muscle mass and may be associated with a leaner, more muscular phenotype in these men and women.